Affiner les résultats

First-line fadrozole HCI (CGS 16949A) versus tamoxifen in postmenopausal women with advanced breast cancer : Prospective randomised trial of the Swiss Group for Clinical Cancer Research SAKK 20/88

Thürlimann, B. ; Beretta, K. ; Bacchi, M. ; Castiglione-Gertsch, M. ; Goldhirsch, A. ; Jungi, W. F. ; Cavalli, F. ; Senn, H.-J ; Fey, M. ; Löhnert, T.

In: Annals of Oncology, 1996, vol. 7, no. 5, p. 471-479